Table 3.
Genotype Distribution of Polymorphisms in all Participants
| Patients, n (%) | Controls, n (%) | OR (95% CI) | p-value | |
|---|---|---|---|---|
| rs705381 | ||||
| CC | 244 (81.33) | 231 (77.00) | Reference | |
| CT | 53 (17.67) | 63 (21.00) | 0.76 (0.50–1.15) | 0.194 |
| TT | 3 (1.00) | 6 (2.00) | 0.43 (0.11–1.76) | 0.241 |
| CT/TT | 56 (18.67) | 65 (23.00) | 0.74 (0.49–1.10) | 0.133 |
| rs854571 | ||||
| CC | 153 (51.00) | 152 (50.67) | Reference | |
| CT | 124 (41.33) | 121 (40.33) | 1.03 (0.73–1.45) | 0.861 |
| TT | 23 (7.67) | 27 (9.00) | 0.82 (0.45–1.50) | 0.517 |
| CT/TT | 147 (49.00) | 148 (49.33) | 0.99 (0.72–1.37) | 0.957 |
| rs854572 | ||||
| CC | 89 (29.67) | 93 (31.00) | Reference | |
| CG | 152 (50.67) | 145 (48.33) | 1.11 (0.77–1.61) | 0.581 |
| GG | 59 (19.67) | 62 (20.67) | 0.98 (0.61–1.57) | 0.939 |
| CG/GG | 211 (70.33) | 207 (69.00) | 1.07 (0.75–1.51) | 0.720 |
| rs3735590 | ||||
| GG | 223 (74.33) | 231 (77.00) | Reference | |
| GA | 70 (23.33) | 64 (21.33) | 1.17 (0.79–1.73) | 0.428 |
| AA | 7 (2.33) | 5 (1.67) | 1.28 (0.40–4.15) | 0.676 |
| GA/AA | 77 (25.67) | 69 (23.00) | 1.19 (0.82–1.74) | 0.365 |
| rs0662 | ||||
| TT | 34 (11.33) | 48 (16.00) | Reference | |
| CT | 154 (51.33) | 129 (43.00) | 1.79 (1.08–2.97) | 0.025 |
| CC | 112 (37.33) | 123 (41.00) | 1.47 (0.87–2.50) | 0.153 |
| CT/CC | 266 (88.67) | 252 (84.00) | 1.58 (0.98–2.55) | 0.063 |
| rs7493 | ||||
| GG | 200 (66.67) | 193 (64.33) | Reference | |
| CG | 87 (29.00) | 92 (30.67) | 0.93 (0.65–1.33) | 0.678 |
| CC | 13 (4.33) | 15 (5.00) | 0.85 (0.39–1.85) | 0.684 |
| CG/CC | 100 (23.33) | 107 (35.67) | 0.91 (0.65–1.28) | 0.602 |